Finally, some good news for all Americans. Indeed, for the entire world.
We are getting closer and closer to a workable vaccine for the dreaded coronavirus and with that the resumption of our pre-plague lives is almost within reach.
This week, it was reported that pharmaceutical company AstraZeneca was set to study trial vaccine data on their vaccine (AZD1222) and determine its efficacy and feasibility. About 23,000 patients are being treated with the product thus far.
“Results from late-stage trials are anticipated later this year, depending on the rate of infection within the…